Patients aged 75 years or older with early upper gastrointestinal cancers
Conditions
Interventions
None listed
Sponsors
Tohoku University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients diagnosed with esophageal/gastric/duodenal tumors by endoscopy (2) Patients diagnosed with cancer by biopsy, or those with tumors strongly suspicious of cancers based on endoscopic findings (3) Patients with esophageal/gastric/duodenal cancers confined to submucosal layer according to endoscopic diagnosis (4) Patients aged 75 years or older (5) Patients with written informed consent for study participation
Exclusion criteria
Exclusion criteria: (1) Patients who refused to participate in this study (2) Patients with esophageal/gastric/duodenal cancers which are suspicious of recurrence (3) Patients who are deemed inappropriate for the study by the investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Factors related to the prognosis at 3 years after the treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The relationship between impaired HR-QoL and sarcopenia or CGA 2. Factors related to impaired HR-QoL at 3 years after the treatment 3. The relationship between the definite diagnosis of sarcopenia and sarcopenia diagnosed by CT 4. Transition of HR-QoL and CGA 5. Prognosis and factors related to prognosis at 1 year and 5 years after the treatment 6. Prevalence and mortality of other organ cancers detected by CT and factors related to them 7. The relationship between sarcopenia-related genes and sarcopenia at 80 years 8. The relationship between sarcopenia-related genes and prognosis | — |
Countries
Japan
Contacts
Public ContactYohei Ogata
Tohoku University Graduate School of Medicine Division of Gastroenterology
Outcome results
None listed